Mucopolysaccharidosis VI
Reference48 articles.
1. Akhtar, S., Tullo, A., Caterson, B., et al. (2002). Clinical and morphological features including expression of betaig-h3 and keratan sulphate proteoglycans in Maroteaux–Lamy syndrome type B and in normal cornea. British Journal of Ophthalmology, 86, 147–151. 2. Alvaro, F., Toogood, I., Fletcher, J. M., et al. (1998). Allogeneic CD34 selected peripheral stem cell transplant for Maroteaux–Lamy syndrome (mucopolysaccharidosis type VI): Rapid haemopoietic and biochemical reconstitution. Bone Marrow Transplantation, 21, 419–421. 3. Bacchus, H., & Peterson, D. I. (1980). Pregnancy complicated by myelopathy due to Maroteaux–Lamy syndrome. American Journal of Obstetrics and Gynecology, 136, 259–260. 4. Bartz, H. J., Wiesner, L., & Wappler, F. (1999). Anaesthetic management of patients with mucopolysaccharidosis IV presenting for major orthopaedic surgery. Acta Anaesthesiologica Scandinavica, 43, 679–683. 5. Black, S. H., Pelias, M. Z., Miller, J. B., et al. (1986). Maroteaux–Lamy syndrome in a large consanguineous kindred: Biochemical and immunological studies. American Journal of Medical Genetics, 25, 273–279.
|
|